Alessandra Musella Selected Research

Alessandra Musella Research Topics

Disease

25	Multiple Sclerosis 05/2024 - 03/2009
23	Inflammation (Inflammations) 10/2023 - 03/2009
19	Experimental Autoimmune Encephalomyelitis (Encephalomyelitis, Autoimmune Experimental) 05/2024 - 03/2009
7	Neuroinflammatory Diseases 05/2024 - 03/2009
5	Disease Progression 01/2022 - 03/2011
3	Neurodegenerative Diseases (Neurodegenerative Disease) 04/2024 - 01/2016
3	Demyelinating Diseases (Demyelinating Disease) 01/2019 - 03/2009
2	Gliosis 01/2018 - 01/2016
2	Pathologic Processes 01/2017 - 01/2016
2	Fragile X Syndrome (Martin Bell Syndrome) 06/2010 - 05/2008
1	COVID-19 10/2023
1	Relapsing-Remitting Multiple Sclerosis 10/2023
1	Cognitive Dysfunction 03/2023
1	Alzheimer Disease (Alzheimer's Disease) 03/2023
1	Mood Disorders (Mood Disorder) 10/2022
1	Necrosis 11/2021
1	Anhedonia 01/2020
1	Obesity 01/2020
1	Fatigue 01/2020
1	Encephalitis (Encephalitis, Rasmussen) 01/2019
1	Ischemic Stroke 11/2012
1	Epilepsy (Aura) 11/2012
1	Adenocarcinoma 07/2012
1	Neoplasms (Cancer) 07/2012
1	Endometrial Neoplasms (Endometrial Cancer) 07/2012
1	Attention Deficit Disorder with Hyperactivity (Attention Deficit Hyperactivity Disorder) 11/2011
1	Substance-Related Disorders (Drug Abuse) 01/2010
1	Amyotrophic Lateral Sclerosis (Lou Gehrig's Disease) 01/2010
1	AIDS-Related Complex (ARC) 03/2009

Drug/Important Bio-Agent (IBA)

11	Glutamic Acid (Glutamate)FDA Link 01/2020 - 03/2009
10	CytokinesIBA 01/2022 - 09/2011
5	CannabinoidsIBA 11/2012 - 01/2010
4	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 01/2018 - 03/2009
3	MicroRNAs (MicroRNA)IBA 01/2023 - 01/2017
2	EndocannabinoidsIBA 04/2024 - 11/2011
2	Proteins (Proteins, Gene)FDA Link 03/2023 - 01/2021
2	EnzymesIBA 03/2023 - 11/2012
2	Biomarkers (Surrogate Marker)IBA 01/2022 - 04/2018
2	Interleukin-6 (Interleukin 6)IBA 01/2022 - 10/2019
2	Interleukin-1beta (Interleukin 1 beta)IBA 11/2021 - 02/2015
2	CuprizoneIBA 01/2019 - 01/2019
2	Neuroprotective AgentsIBA 01/2018 - 01/2016
2	Cannabinoid Receptors (Cannabinoid Receptor)IBA 01/2016 - 04/2014
2	Neurotransmitter Agents (Neurotransmitter)IBA 01/2015 - 01/2012
2	CB1 Cannabinoid Receptor (CB1 Receptor)IBA 11/2011 - 03/2011
2	gamma-Aminobutyric Acid (GABA)IBA 07/2011 - 05/2008
1	Interleukin-9 (Interleukin 9)IBA 05/2024
1	glyceryl 2-arachidonate (2-arachidonoylglycerol)IBA 04/2024
1	VaccinesIBA 10/2023
1	Messenger RNA (mRNA)IBA 10/2023
1	Amyloid (Amyloid Fibrils)IBA 03/2023
1	Interleukin-8 (Interleukin 8)IBA 01/2023
1	Interleukin-2 (IL2)IBA 10/2022
1	Brain-Derived Neurotrophic Factor (BDNF)IBA 10/2022
1	ParvalbuminsIBA 11/2021
1	LipidsIBA 01/2020
1	InterleukinsIBA 01/2020
1	Sphingosine-1-Phosphate ReceptorsIBA 01/2020
1	Lysophosphatidylcholines (Lysophosphatidylcholine)IBA 01/2019
1	Platelet-Derived Growth FactorIBA 04/2018
1	Intercellular Signaling Peptides and Proteins (Growth Factors)IBA 04/2018
1	Amino Acid Transport System X-AG (Glutamate Transporter)IBA 01/2018
1	laquinimodIBA 01/2018
1	InterferonsIBA 12/2017
1	siponimodIBA 01/2016
1	Cladribine FDA LinkGeneric 11/2013
1	Interleukin 1 Receptor Antagonist Protein (Anakinra)FDA Link 07/2013
1	Glatiramer Acetate (Copaxone)FDA Link 06/2013
1	HU 211 (HU 210)IBA 11/2012
1	cyclohexyl carbamic acid 3'-carbamoylbiphenyl-3-yl ester (URB597)IBA 11/2012
1	fatty-acid amide hydrolase (fatty acid amide hydrolase)IBA 11/2012
1	Cannabinoid Receptor AgonistsIBA 11/2012
1	Cisplatin (Platino)FDA LinkGeneric 07/2012
1	Therapeutic UsesIBA 07/2012
1	Antineoplastic Agents (Antineoplastics)IBA 07/2012
1	Cocaine (Cocaine HCl)IBA 11/2011
1	Dopamine Plasma Membrane Transport Proteins (Dopamine Transporter)IBA 11/2011
1	GABA-B ReceptorsIBA 11/2011
1	Dopamine (Intropin)FDA LinkGeneric 11/2011
1	Fragile X Mental Retardation ProteinIBA 06/2010
1	Sucrose (Saccharose)IBA 01/2010
1	Myelin-Oligodendrocyte GlycoproteinIBA 10/2009
1	AMPA Receptors (AMPA Receptor)IBA 03/2009

Therapy/Procedure

2	Therapeutics 11/2021 - 03/2009
1	Immunomodulation 10/2022
1	Transcranial Magnetic Stimulation 01/2022